by CheckRare Staff | Aug 4, 2023
Michael Thorner, MB, Vice President of Endocrine Science at Lumos Pharma discusses the latest research on LUM 201 (ibutamoren) to treat idiopathic pediatric growth hormone deficiency. Growth hormone deficiency is a rare endocrine disorder....
by CheckRare Staff | Aug 3, 2023
Vera Bril, MD, Professor of Medicine at the University of Toronto discusses the recent approval rozanolixizumab to treat myasthenia gravis. Myasthenia gravis is a chronic autoimmune neuromuscular disease characterized by weakness of the skeletal...
by CheckRare Staff | Aug 2, 2023
Vera Bril, MD, Professor of Medicine at the University of Toronto discusses rozanolixizumab’s treatment mechanism to treat myasthenia gravis. Myasthenia gravis is a chronic autoimmune neuromuscular disease characterized by weakness of the skeletal...
by CheckRare Staff | Aug 1, 2023
Scott Schobel, MD, Chief Medical Officer at Vico Therapeutics, discusses current treatment options for Huntington’s disease and spinocerebellar ataxia (SCA1 and SCA3). Huntington’s disease is a rare neurodegenerative disorder characterized by...
by CheckRare Staff | Jul 31, 2023
Binod Dhakal, MD, Associate Professor at the Medical College of Wisconsin discusses current treatment options for patients with refractory or relapsed multiple myeloma. Multiple myeloma is a rare blood cancer associated with uncontrolled growth of plasma...
